According to a notice published today on the Food and Drug Administration website, FDA is investigating the possible association between the use of tumor necrosis factor (TNF) inhibitors and the development of lymphoma and other cancers in children and young adults. These individuals were treated with TNF blockers for Juvenile Idiopathic Arthritis (JIA), Crohn's disease or other diseases.
If you, your child or a patient of yours has developed cancer or another serious side effect while ...
Read more »...arthritis either of the small joints, or large joints (Ankylosing spondylitis or sacroilitis);... Read more »
...that occurs; peripheral arthritis, spondylitis and ankylosing spondylitis. Peripheral arthritis... Read more »
...types of arthritis (e.g., rheumatoid, psoriatic, and ankylosing spondylitis). This medication is... Read more »
...types of arthritis (e.g., rheumatoid, psoriatic, and ankylosing spondylitis). This medication is... Read more »
...types of arthritis (e.g., rheumatoid, psoriatic, and ankylosing spondylitis), as well as a skin... Read more »
Drugmaker Abbott has launched Humira for the treatment of Crohn's disease in the United Kingdom. In April, the European Medicines Agency recommended... Read summary »
Drugmaker Abbott has applied to the Food and Drug Administration for approval to use Humira for the treatment of moderate to severe Crohn's disease.... Read summary »
The Food and Drug Administration has approved Humira for a new use. Humira may now be used to slow joint damage in people with psoriatic arthritis.... Read summary »
(Ivanhoe Newswire) -- Although the treatment of heart failure has improved over the past 20 years, new research suggests treatments may differ... Read summary »
(Ivanhoe Newswire) Two new studies suggest doctors could do a better job when it comes to caring for the heart. European researchers who surveyed... Read summary »